Page last updated: 2024-08-25

atovaquone and Parasitemia

atovaquone has been researched along with Parasitemia in 49 studies

Research

Studies (49)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (14.29)18.2507
2000's18 (36.73)29.6817
2010's20 (40.82)24.3611
2020's4 (8.16)2.80

Authors

AuthorsStudies
Clark, JA; Connelly, MC; El Mazouni, F; Furimsky, A; Gow, J; Guiguemde, WA; Guy, RK; Iyer, L; Kyle, DE; Min, J; Mirsalis, J; Parman, T; Phillips, MA; Pradhan, A; Zhang, Y; Zhu, F1
Bathurst, I; Burrows, JN; Charman, SA; Cross, RM; Flanigan, DL; Fronczek, FR; Guida, WC; Kyle, DE; LaCrue, AN; Maignan, JR; Manetsch, R; Monastyrskyi, A; Mutka, TS; Sáenz, FE; Shackleford, DM; White, KL; Wojtas, L1
Azas, N; Basmaciyan, L; Cohen, A; Crozet, MD; Dallemagne, P; Deharo, E; Dumètre, A; Hutter, S; Laget, M; Lancelot, JC; Lesnard, A; Lorthiois, A; Mazier, D; Paloque, L; Rathelot, P; Rault, S; Sibley, CH; Suzanne, P; Valentin, A; Vanelle, P; Verhaeghe, P1
Jacobs, JW; Siddon, AJ1
Ivancich, M; Lutwick, L; Shweta, FNU1
Handel, AS; Hellman, H; Hymes, SR1
Chenet, SM; Fernandez, J; Jercic, MI; Lucchi, NW; Oyarce, A; Tapia-Limonchi, R; Tejedo, JR; Udhayakumar, V; Weitzel, T1
Chiu, JE; Dodean, R; Doggett, JS; Frueh, L; Gihaz, S; Kumar, M; Mamoun, CB; Nilsen, AC; Pal, AC; Pou, S; Renard, I; Riscoe, MK; Singh, P; Thekkiniath, J; Vydyam, P; Winter, RW1
Almela, MJ; Angulo-Barturen, Í; Bamborough, P; Burrows, J; Calderón, F; Cammack, N; Castañeda, P; Chaparro, MJ; Coterón, JM; Crespo, B; de Cozar, C; de la Rosa, JC; de Mercado, J; Díaz, B; Drewes, G; Fernández, E; Ferrer-Bazaga, S; Fraile, MT; Gamo, FJ; Ghidelli-Disse, S; Gómez, R; Haselden, J; Huss, S; Jiménez Díaz, MB; Lafuente-Monasterio, MJ; León, ML; Macdonald, SJF; Martín Hernando, JI; Martínez-Martínez, MS; Prats, S; Puente, M; Rodríguez, A; Rueda, L; Sandoval, E; Selenski, C; Vidal, J; Willis, P; Wilson, DM; Witty, M1
Charunwatthana, P; Chotivanich, K; Dondorp, AM; Färnert, A; Herder, C; Holmer, E; Kiwuwa, MS; Kristensen, J; Lee, SJ; Leitgeb, AM; Lindgren, M; Moll, K; Rueangveerayut, R; Sila, P; Silamut, K; Tarning, J; Uthaisin, C; Wahlgren, M1
Berman, J; DiTusa, C; Gettayacamin, M; Im-erbsin, R; Kozar, MP; Ohrt, C; Pybus, B; Sousa, J; Tungtaeng, A1
Hikasa, Y; Iguchi, A; Matsuu, A; Shiranaga, N1
Akala, HM; Auschwitz, JM; Cheruiyot, AC; Gaona, HW; Hickman, MR; Johnson, JD; Kamau, E; Lee, PJ; Leed, SE; Murthy, T; Okello, CO; Talwar, M; Yeda, RA1
Bouchaud, O; Bruneel, F; Camus, C; Caumes, E; Choquet, C; Corne, P; Durand, R; Gibot, S; Girard, PM; Houze, S; Huisse, MG; Kalloumeh, A; Le Bras, J; Matheron, S; Megarbane, B; Mira, JP; Peytel, E; Roy, C; Simon, F; Tubach, F; Villers, D; Wolff, M1
Forquer, IP; Kelly, JX; Li, Y; Morrisey, JM; Nilsen, A; Pou, S; Riscoe, MK; Smilkstein, MJ; Stickles, AM; Vaidya, AB; Winter, RW1
Bartolomé, A; Checa, R; Gálvez, R; González-Fraga, JL; Marino, V; Miró, G; Montoya, A; Ortega, N1
Benoit-Vical, F; Berry, A; Garcia-Alvarez, MC; Nicolau, ML; Olagnier, D; Soh, PN; Witkowski, B1
Burke, M; Chiodini, PL; Fivelman, QL; Klein, JL; Laundy, M; Pasvol, G; Price, N; Sutherland, CJ1
Bensch, S; Bolshakov, CV; Krizanauskiene, A; Palinauskas, V; Valkiūnas, G1
Boggild, AK; Kain, KC; Katz, K; Krudsood, S; Liles, WC; Looareesuwan, S; Patel, SN; Serghides, L; Tangpukdee, N; Wilairatana, P1
Aguero-Rosenfeld, M; Joshi, S; Krause, PJ; Mittleman, A; Nelson, J; Neuhaus, E; Nowakowski, J; Prasad, A; Topal, J; Wormser, GP1
Forestier, E; Labe, A; Lecomte, C; Raffenot, D; Rogeaux, O1
Lubin, AS; Miller, KB; Snydman, DR1
Bautista, JM; Diez, A; García-Granados, A; Marín-García, P; Moneriz, C; Puyet, A1
Ganesan, SM; Ke, H; Mather, MW; Morrisey, JM; Painter, HJ; Vaidya, AB1
Clemens, EG; Deye, GA; Dumler, JS; Fracisco, S; Macareo, L; Magill, AJ; Miller, L; Miller, RS; Murphy, J; Salas, CJ; Smith, BL; Sousa, JC; Tosh, D1
Basco, LK; Delmont, J; Moyou-Somo, R; Ngane Foumane, V; Sayang, C; Soula, G; Tahar, R1
Borrmann, S; Erkens, MA; Graumans, W; Heinrichs, MJ; Hermsen, CC; Hoffman, SL; Luty, AJ; Nganou-Makamdop, K; Roestenberg, M; Rozier, YP; Sauerwein, RW; Scholzen, A; Siebelink-Stoter, R; Sim, BK; Teelen, K; Teirlinck, AC; van de Vegte-Bolmer, M; van Gemert, GJ; van Lieshout, L; Visser, LG; Vos, MW1
Binh, TQ; De Vries, PJ; Giao, PT; Hung, LQ; Kager, PA; Nam, NV1
Binh, TQ; de Vries, PJ; Giao, PT; Hung, le Q; Kager, PA; Nam, NV1
Ashley, EA; Barends, M; Cho, T; Hutagalung, R; Looareesuwan, S; McGready, R; Moo, E; Nosten, F; White, NJ1
Berzins, K; Grandien, A; Hagstedt, M; Nyakeriga, AM; Perlmann, H; Perlmann, P; Troye-Blomberg, M; Zhivotovsky, B1
Bennett, S; Fielding, K; Greenwood, B; Malunga, P; Mulenga, M; Shulman, C; Thuma, P1
Alloueche, A; Bennett, S; Fielding, K; Greenwood, BM; Malunga, F; Mulenga, M; Shulman, C; Thuma, PE1
Chollet, J; Santo-Tomas, J; Scheurer, C; Snyder, C; Wittlin, S1
Abreu-Acosta, N; Foronda, P; Lorenzo-Morales, J; Orós, J; Ortega-Rivas, A; Santana-Morales, MA; Valladares, B1
Irwin, PJ; Jardine, J; Jefferies, R; Robertson, ID; Ryan, UM1
Burgner, D; Cherian, S1
Kita, K; Marzuki, S; Matsuoka, H; Siregar, JE; Syafruddin, D1
Ballou, WR; Heppner, DG; Lievens, M; Ogutu, B; Polhemus, ME; Remich, S; Waitumbi, J1
Kain, KC; Le Saux, N; McCarthy, AE; Rose, GW; Suh, KN1
Hughes, WT; Oz, HS1
Lederman, J; Rosenbaum, GS; Tanowitz, HB; Weiss, LM; Wittner, M1
Gray, JS; Pudney, M1
Aleman, GM; Gordon, DM; Klotz, FW; Oloo, AJ; Sadie, D; Scott, TR; Shanks, GD1
Aumjaud, Y; Derouin, F; Fessi, H; Sordet, F1
Barditch-Crovo, P; Kumar, N; Ranasinha, CD; Shapiro, TA1
Chisdaka, N; Mulenga, M; Roskell, NS; Scott, TR; Sukwa, TY1
Adagu, IS; Butcher, GA; Fivelman, QL; Pasvol, G; Warhurst, DC1

Trials

12 trial(s) available for atovaquone and Parasitemia

ArticleYear
Inhibition of merozoite invasion and transient de-sequestration by sevuparin in humans with Plasmodium falciparum malaria.
    PloS one, 2017, Volume: 12, Issue:12

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antimalarials; Area Under Curve; Atovaquone; Binding, Competitive; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Erythrocytes; Female; Heparin; Heparitin Sulfate; Humans; Infusions, Intravenous; Malaria, Falciparum; Male; Merozoites; Middle Aged; Parasite Load; Parasitemia; Plasmodium falciparum; Proguanil; Severity of Illness Index

2017
Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Sep-15, Volume: 49, Issue:6

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Animals; Antimalarials; Atovaquone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunity, Innate; Inflammation; Inflammation Mediators; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; PPAR gamma; Proguanil; Rosiglitazone; Thailand; Thiazolidinediones; Time Factors; Treatment Outcome; Young Adult

2009
Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Jan-15, Volume: 54, Issue:2

    Topics: Adult; Antimalarials; Area Under Curve; Atovaquone; Chemoprevention; Cohort Studies; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Placebos; Plasmodium falciparum; Proguanil; Sporozoites

2012
NF135.C10: a new Plasmodium falciparum clone for controlled human malaria infections.
    The Journal of infectious diseases, 2013, Feb-15, Volume: 207, Issue:4

    Topics: Adolescent; Adult; Animals; Anopheles; Antimalarials; Atovaquone; Genotype; Humans; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Proguanil; Treatment Outcome; Young Adult

2013
CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam.
    Tropical medicine & international health : TM & IH, 2004, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Atovaquone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Primaquine; Proguanil; Quinolines; Sesquiterpenes; Treatment Outcome; Trimethoprim; Vietnam

2004
A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy.
    The Journal of infectious diseases, 2005, Sep-01, Volume: 192, Issue:5

    Topics: Adolescent; Adult; Anemia; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Naphthoquinones; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Proguanil; Quinine; Sesquiterpenes; Thailand

2005
Folic acid treatment of Zambian children with moderate to severe malaria anemia.
    The American journal of tropical medicine and hygiene, 2006, Volume: 74, Issue:6

    Topics: Anemia; Animals; Antimalarials; Atovaquone; Child; Child, Preschool; Drug Combinations; Folic Acid; Hematinics; Humans; Infant; Malaria, Falciparum; Naphthoquinones; Parasitemia; Population Density; Proguanil; Pyrimethamine; Sulfadoxine; Treatment Failure; Zambia

2006
A randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children.
    Tropical medicine & international health : TM & IH, 2006, Volume: 11, Issue:11

    Topics: Anemia; Antimalarials; Atovaquone; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Prevalence; Proguanil; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Failure; Zambia

2006
Malaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Adolescent; Adult; Animals; Antimalarials; Atovaquone; Chemoprevention; Humans; Kaplan-Meier Estimate; Kenya; Malaria Vaccines; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Proguanil; Time Factors

2008
Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 27, Issue:3

    Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Female; Humans; Kenya; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Parasitemia; Proguanil; Treatment Outcome

1998
Prophylactic activity of atovaquone against Plasmodium falciparum in humans.
    The American journal of tropical medicine and hygiene, 1999, Volume: 60, Issue:5

    Topics: Adolescent; Adult; Animals; Anopheles; Antimalarials; Atovaquone; Double-Blind Method; Humans; Insect Bites and Stings; Malaria, Falciparum; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction

1999
A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone/proguanil) for the prophylaxis of malaria in Zambia.
    The American journal of tropical medicine and hygiene, 1999, Volume: 60, Issue:4

    Topics: Adolescent; Adult; Animals; Antimalarials; Atovaquone; Double-Blind Method; Drug Combinations; Humans; Malaria, Falciparum; Male; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Proguanil; Zambia

1999

Other Studies

37 other study(ies) available for atovaquone and Parasitemia

ArticleYear
Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials.
    Journal of medicinal chemistry, 2012, May-10, Volume: 55, Issue:9

    Topics: Administration, Oral; Animals; Antimalarials; Biological Availability; Female; Hep G2 Cells; Humans; Malaria, Falciparum; Mice; Mice, Inbred ICR; Nuclear Magnetic Resonance, Biomolecular; Parasitemia; Plasmodium falciparum; Quinolines; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship

2012
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
    Journal of medicinal chemistry, 2014, Nov-13, Volume: 57, Issue:21

    Topics: Animals; Antimalarials; Humans; Inhibitory Concentration 50; Malaria; Mice; Microsomes, Liver; Parasitemia; Plasmodium; Plasmodium berghei; Quinolones; Structure-Activity Relationship

2014
Discovery of new thienopyrimidinone derivatives displaying antimalarial properties toward both erythrocytic and hepatic stages of Plasmodium.
    European journal of medicinal chemistry, 2015, May-05, Volume: 95

    Topics: Animals; Antimalarials; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Drug Discovery; Erythrocytes; Hep G2 Cells; Humans; Liver; Malaria; Male; Mice; Parasitemia; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship; Trophozoites

2015
Concurrent COVID-19 and babesiosis in an older, splenectomized patient.
    Blood, 2021, 11-25, Volume: 138, Issue:21

    Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atovaquone; Azithromycin; Babesiosis; BNT162 Vaccine; COVID-19; COVID-19 Drug Treatment; Fever; Humans; Leukemia, Myeloid, Acute; Male; Parasitemia; Remission Induction; SARS-CoV-2; Splenectomy

2021
Trust the Process: Prolonged Babesia Parasitemia in an Elderly Man with Asplenia from the American Midwest.
    The American journal of case reports, 2022, Jul-18, Volume: 23

    Topics: Aged; Aged, 80 and over; Atovaquone; Azithromycin; Babesia; Babesiosis; Humans; Male; Parasitemia; Trust; United States

2022
Two Neonates With Postnatally Acquired Tickborne Infections.
    Pediatrics, 2019, Volume: 144, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Atovaquone; Azithromycin; Babesiosis; Ceftriaxone; Erythema Chronicum Migrans; Exanthema; Female; Humans; Infant, Newborn; Parasitemia; Tick Bites

2019
Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile.
    The American journal of tropical medicine and hygiene, 2021, 03-29, Volume: 104, Issue:5

    Topics: Adult; Antimalarials; Artesunate; Atovaquone; Chile; Cytochromes b; Drug Combinations; Drug Resistance; Female; Gene Expression; Humans; Malaria, Falciparum; Male; Mefloquine; Mutation; Nigeria; Parasitemia; Plasmodium falciparum; Proguanil; Protozoan Proteins; Recurrence; Tetrahydrofolate Dehydrogenase; Travel

2021
Effective Therapy Targeting Cytochrome
    Antimicrobial agents and chemotherapy, 2021, 08-17, Volume: 65, Issue:9

    Topics: Animals; Atovaquone; Babesia; Babesiosis; Cytochromes; Mice; Parasitemia

2021
The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide Scaffold.
    Journal of medicinal chemistry, 2017, 08-24, Volume: 60, Issue:16

    Topics: 2,2'-Dipyridyl; Animals; Antimalarials; Atovaquone; Chloroquine; Drug Design; Female; Humans; Hydrazines; Mice; Mutagenicity Tests; Mutagens; Oxadiazoles; Parasitemia; Plasmodium falciparum; Pyrimethamine; Structure-Activity Relationship

2017
Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.
    The Journal of parasitology, 2014, Volume: 100, Issue:5

    Topics: Aminoquinolines; Animals; Antimalarials; Atovaquone; Disease Models, Animal; Drug Combinations; Macaca mulatta; Malaria; Parasitemia; Plasmodium cynomolgi; Primaquine; Proguanil

2014
Efficacy of Malarone(®) in dogs naturally infected with Babesia gibsoni.
    The Journal of veterinary medical science, 2014, Volume: 76, Issue:9

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Atovaquone; Babesia; Babesiosis; Bilirubin; Blood Cell Count; Blood Urea Nitrogen; Creatinine; DNA, Protozoan; Dog Diseases; Dogs; Doxycycline; Drug Combinations; Drug Therapy, Combination; Female; Globulins; Male; Parasitemia; Polymerase Chain Reaction; Proguanil; Serum Albumin

2014
Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4

    Topics: Antimalarials; Artemisinins; Atovaquone; Benzothiazoles; Biological Assay; Chloroquine; Diamines; DNA, Protozoan; Drug Resistance; Erythrocytes; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Organic Chemicals; Parasitemia; Plasmodium falciparum; Public Health Surveillance; Quinolines; Reproducibility of Results; Sensitivity and Specificity

2016
Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.
    Intensive care medicine, 2016, Volume: 42, Issue:10

    Topics: Adult; Analysis of Variance; Animals; Antigens, Protozoan; Antimalarials; Atovaquone; Biomarkers; C-Reactive Protein; Calcitonin; Drug Combinations; Female; France; Host-Parasite Interactions; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Proguanil; Prospective Studies; Protozoan Proteins; Quinine; Severity of Illness Index

2016
Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8

    Topics: Animals; Antimalarials; Atovaquone; Drug Combinations; Drug Therapy, Combination; Electron Transport Complex III; Female; Malaria, Falciparum; Mice; Parasitemia; Plasmodium falciparum; Proguanil; Quinolones

2016
Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.
    Parasites & vectors, 2017, Mar-13, Volume: 10, Issue:1

    Topics: Animals; Antiprotozoal Agents; Atovaquone; Azithromycin; Babesia microti; Babesiosis; Dog Diseases; Dogs; Drug Therapy, Combination; Europe; Female; Imidocarb; Male; Naphthoquinones; Parasitemia; Polymerase Chain Reaction

2017
In vitro and in vivo properties of ellagic acid in malaria treatment.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Chloroquine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ellagic Acid; Erythrocytes; Female; Inhibitory Concentration 50; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred Strains; Molecular Structure; Molecular Weight; Parasitemia; Parasitic Sensitivity Tests; Plasmodium; Plasmodium falciparum; Schizonts; Trophozoites

2009
Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
    Malaria journal, 2008, Nov-20, Volume: 7

    Topics: Adult; Animals; Antimalarials; Atovaquone; Child, Preschool; Cytochromes b; DNA, Protozoan; Drug Combinations; Drug Therapy, Combination; Female; Genotype; Humans; Malaria, Falciparum; Male; Middle Aged; Mutation; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Proguanil; Recurrence; Time Factors; Treatment Failure

2008
Plasmodium relictum (lineage P-SGS1): Further observation of effects on experimentally infected passeriform birds, with remarks on treatment with Malarone.
    Experimental parasitology, 2009, Volume: 123, Issue:2

    Topics: Animals; Antimalarials; Atovaquone; Disease Susceptibility; Drug Combinations; Finches; Hematocrit; Malaria, Avian; Male; Parasitemia; Plasmodium; Proguanil; Species Specificity; Virulence

2009
Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Feb-01, Volume: 50, Issue:3

    Topics: Aged, 80 and over; Animals; Antiprotozoal Agents; Atovaquone; Azithromycin; Babesia microti; Babesiosis; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Male; Middle Aged; Parasitemia

2010
[Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment].
    Medecine et maladies infectieuses, 2011, Volume: 41, Issue:1

    Topics: Antimalarials; Atovaquone; Cerebrospinal Fluid; Cognition Disorders; Confusion; Diagnosis, Differential; Drug Therapy, Combination; Encephalitis, Herpes Simplex; Hepatitis; Humans; Lymphocyte Count; Malaria, Cerebral; Malaria, Falciparum; Male; Meningitis, Aseptic; Middle Aged; Parasitemia; Proguanil; Recurrence; Syndrome

2011
Persistent babesiosis in a stem cell transplant recipient.
    Leukemia research, 2011, Volume: 35, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Antimalarials; Atovaquone; Azithromycin; Babesia; Babesiosis; Drug Resistance; Drug Therapy, Combination; Humans; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Parasitemia; Stem Cell Transplantation

2011
Parasitostatic effect of maslinic acid. I. Growth arrest of Plasmodium falciparum intraerythrocytic stages.
    Malaria journal, 2011, Apr-10, Volume: 10

    Topics: Antimalarials; Atovaquone; Chloroquine; Erythrocytes; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Triterpenes

2011
Variation among Plasmodium falciparum strains in their reliance on mitochondrial electron transport chain function.
    Eukaryotic cell, 2011, Volume: 10, Issue:8

    Topics: Antimalarials; Atovaquone; Cells, Cultured; Dihydroorotate Dehydrogenase; Drug Resistance; Electron Transport; Fungal Proteins; Humans; Mitochondria; Organisms, Genetically Modified; Oxidoreductases Acting on CH-CH Group Donors; Parasitemia; Plasmodium falciparum; Recombinant Proteins; Ubiquinone

2011
Field evaluation of rapid diagnostic tests for malaria in Yaounde, Cameroon.
    Acta tropica, 2013, Volume: 125, Issue:2

    Topics: Adult; Antigens, Protozoan; Atovaquone; Cameroon; Child, Preschool; Drug Combinations; Follow-Up Studies; Humans; Infant; L-Lactate Dehydrogenase; Likelihood Functions; Malaria; Parasite Load; Parasitemia; Plasmodium; Predictive Value of Tests; Proguanil; Protozoan Proteins; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Treatment Outcome

2013
Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam.
    Annals of tropical medicine and parasitology, 2003, Volume: 97, Issue:6

    Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Naphthoquinones; Parasitemia; Plasmodium falciparum; Proguanil; Recurrence; Sesquiterpenes; Treatment Failure; Vietnam

2003
Drug-induced death of the asexual blood stages of Plasmodium falciparum occurs without typical signs of apoptosis.
    Microbes and infection, 2006, Volume: 8, Issue:6

    Topics: Animals; Antimalarials; Apoptosis; Atovaquone; Cells, Cultured; Chloroquine; DNA Fragmentation; DNA, Protozoan; Enzyme Inhibitors; Erythrocytes; Etoposide; Flow Cytometry; Humans; In Situ Nick-End Labeling; Malaria, Falciparum; Membrane Potentials; Mitochondrial Membranes; Naphthoquinones; Nitric Oxide Donors; Parasitemia; Penicillamine; Plasmodium falciparum

2006
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
    Experimental parasitology, 2007, Volume: 115, Issue:3

    Topics: Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Erythrocytes; Female; Heterocyclic Compounds, 1-Ring; Humans; Malaria; Mice; Parasitemia; Parasitic Sensitivity Tests; Peroxides; Plasmodium berghei; Plasmodium falciparum; Pyrimethamine; Quinolines; Spiro Compounds

2007
Clinical efficacy of antiparasite treatments against intestinal helminths and haematic protozoa in Gallotia caesaris (lizards).
    Experimental parasitology, 2007, Volume: 116, Issue:4

    Topics: Animals; Antiparasitic Agents; Atovaquone; Chloroquine; Drug Combinations; Feces; Fenbendazole; Helminthiasis, Animal; Intestinal Diseases, Parasitic; Lizards; Parasitemia; Pilot Projects; Proguanil; Protozoan Infections, Animal

2007
Babesia gibsoni: detection during experimental infections and after combined atovaquone and azithromycin therapy.
    Experimental parasitology, 2007, Volume: 117, Issue:2

    Topics: Acute Disease; Animals; Anti-Infective Agents; Antibodies, Protozoan; Atovaquone; Azithromycin; Babesia; Babesiosis; Chronic Disease; DNA, Protozoan; Dog Diseases; Dogs; Drug Resistance; Female; Fluorescent Antibody Technique; Parasitemia; Polymerase Chain Reaction

2007
Selective ambulatory management of Plasmodium falciparum malaria in paediatric refugees.
    Archives of disease in childhood, 2007, Volume: 92, Issue:11

    Topics: Adolescent; Ambulatory Care; Antimalarials; Atovaquone; Australia; Child; Child, Preschool; Female; Follow-Up Studies; Hospitalization; Humans; Malaria, Falciparum; Male; Mefloquine; Parasitemia; Patient Compliance; Proguanil; Quinine; Refugees

2007
Mutation underlying resistance of Plasmodium berghei to atovaquone in the quinone binding domain 2 (Qo(2)) of the cytochrome b gene.
    Parasitology international, 2008, Volume: 57, Issue:2

    Topics: Amino Acid Sequence; Animals; Antimalarials; Atovaquone; Benzoquinones; Cytochrome b Group; Drug Resistance; Malaria; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Mutation; Parasitemia; Parasitic Sensitivity Tests; Plasmodium berghei

2008
Atovaquone-proguanil resistance in imported falciparum malaria in a young child.
    The Pediatric infectious disease journal, 2008, Volume: 27, Issue:6

    Topics: Animals; Antimalarials; Atovaquone; Child; Cytochromes c; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Male; Mozambique; Mutation, Missense; North America; Parasitemia; Plasmodium falciparum; Proguanil; Treatment Failure

2008
Successful prevention and treatment of babesiosis with atovaquone.
    The Journal of infectious diseases, 1995, Volume: 172, Issue:4

    Topics: Animals; Antiprotozoal Agents; Atovaquone; Babesiosis; Chemoprevention; Cricetinae; Dexamethasone; Evaluation Studies as Topic; Glucocorticoids; Immunosuppression Therapy; Male; Naphthoquinones; Parasitemia; Survival Analysis

1995
Atovaquone in the treatment of Babesia microti infections in hamsters.
    The American journal of tropical medicine and hygiene, 1996, Volume: 55, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Antimalarials; Antiprotozoal Agents; Artemisinins; Atovaquone; Azithromycin; Babesiosis; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Naphthoquinones; Parasitemia; Recurrence; Sesquiterpenes

1996
Therapeutic efficacy of atovaquone against the bovine intraerythrocytic parasite, Babesia divergens.
    The Journal of parasitology, 1997, Volume: 83, Issue:2

    Topics: Acute Disease; Animals; Antiprotozoal Agents; Atovaquone; Babesia; Babesiosis; Cattle; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Erythrocytes; Gerbillinae; Hemoglobinuria; Humans; Naphthoquinones; Parasitemia; Regression Analysis

1997
Assessment of the activity of atovaquone-loaded nanocapsules in the treatment of acute and chronic murine toxoplasmosis.
    Parasite (Paris, France), 1998, Volume: 5, Issue:3

    Topics: Acute Disease; Administration, Oral; Animals; Antiprotozoal Agents; Atovaquone; Brain; Capsules; Chronic Disease; Colloids; Disease Models, Animal; Drug Carriers; Drug Stability; Female; Lung; Mice; Naphthoquinones; Parasitemia; Solubility; Survival Rate; Suspensions; Temperature; Toxoplasma; Toxoplasmosis, Animal

1998
Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria.
    Malaria journal, 2002, Feb-08, Volume: 1

    Topics: Amino Acid Substitution; Animals; Antimalarials; Atovaquone; Codon; Cytochromes b; Drug Combinations; Drug Resistance; Humans; London; Malaria, Falciparum; Male; Middle Aged; Mutation, Missense; Naphthoquinones; Nigeria; Parasitemia; Plasmodium falciparum; Proguanil; Protozoan Proteins; Travel

2002